City page
Turku biotech and pharma directory
This page shows why the city matters, which categories are strongest there, and which compliance or quality markers are already visible in public evidence.
Where does this city read strongest?
Diagnostics (3), Therapeutics (1), and CDMO (1). Most visible records: Bayer Oy Turku Product Supply Center, Wallac Oy (Revvity), and Abacus Diagnostica.
Which standards and public evidence are already visible?
GMP (3), ISO-13485 (2), and FDA-Inspected (3). Latest review: 24 April 2026. Review cycle: April 2026.
Why does this city matter?
This page brings visible companies and infrastructure records into one practical view of Turku.
By category
Turku by category
Jump into a category page filtered to this country only.
Full list
Turku biotech and pharma directory
7 city records currently match the active filter.
Current review cycle
Bayer Oy Turku Product Supply Center
TurkuFinlandManufacturing
Turku pharmaceutical manufacturing site producing hormonal IUDs (Mirena, Kyleena, Jaydess) for Bayer's global contraceptive portfolio, with a disclosed 250 million EUR automated plant expansion opened in 2025.
- Lead
- Tomi PenttilaHead of Bayer Product Supply Center, Turku
- Scale
- Commercial specialty pharmaceutical manufacturing
Current review cycle
Wallac Oy (Revvity)
TurkuFinlandDiagnostics
Turku IVD manufacturing and diagnostics R&D site, developing neonatal and prenatal screening assays (DELFIA, AutoDELFIA) and global newborn-screening instruments; now part of Revvity (Wallac Oy legal entity continues).
- Lead
- Petra FuruGeneral Manager, Reproductive Health (Turku)
- Scale
- Commercial IVD manufacturing
Current review cycle
Abacus Diagnostica
TurkuFinlandDiagnostics
Turku molecular-diagnostics company developing rapid PCR, sample-to-answer testing, and infectious-disease diagnostic products from Finland.
- Lead
- Petri SalonenCEO
- Scale
- Commercial diagnostics platform
Current review cycle
DelSiTech
TurkuFinlandBiotech
Turku drug-delivery company building silica-based controlled-release platforms for pharmaceutical and biomedical applications.
- Lead
- Sari JalkanenCEO
- Scale
- Specialized drug-delivery platform
Current review cycle
ArcDia International
TurkuFinlandDiagnostics
Turku in-vitro diagnostics company developing automated mariPOC testing systems for infectious-disease diagnostics and near-patient laboratory workflows.
- Lead
- Janne KoskinenCEO and CSO
- Scale
- Commercial diagnostics platform
Current review cycle
3PBIOVIAN
TurkuFinlandCDMO
Turku biologics and viral-vector CDMO site offering microbial proteins, plasmid DNA, viral vectors, aseptic fill-finish, and QC services under EMA-certified and FDA-inspected GMP operations.
- Lead
- Damaso MoleroChief Executive Officer
- Scale
- Investigational to commercial GMP manufacturing
Current review cycle
Faron Pharmaceuticals
TurkuFinlandTherapeutics
Turku immunotherapy headquarters advancing macrophage reprogramming and hematology-oncology programs through regulated clinical development.
- Lead
- Juho JalkanenChief Executive Officer
- Scale
- Clinical-stage therapeutic development
Related briefs
Briefs that mention Turku
Viral Vector CDMO Europe 2026: AAV, Adenovirus, Lentivirus
Where to manufacture viral vectors in Europe in 2026 — FinVector, Kuopio Center for Gene and Cell Therapy, 3PBIOVIAN, Fuse Vectors, IDT Biologika — and how the European viral vector CDMO layer is structured.
Open briefNordic Biotech Landscape 2026: Denmark, Sweden, Finland, Norway
A practical map of the Nordic biotech and pharma landscape in 2026 — 124 operators across Denmark, Sweden, Finland, and Norway, anchored by Novo Nordisk, Genmab, Lundbeck, AstraZeneca Gothenburg, Bavarian Nordic, Orion, and a dense Medicon Valley + Karolinska cluster layer.
Open briefCell & Gene Therapy Europe 2026: CAR-T, Stem Cell, ATMP, Regenerative
A practical map of the European cell and gene therapy landscape in 2026 — CAR-T and TCR-T therapeutics, stem-cell and regenerative ATMPs, tissue engineering, plus the viral-vector CDMO and tools supply chain — across 26 operators in the directory.
Open briefNext step
Read the city, then widen the view.
Use country and regional pages for wider context, and the company suggestion form for new candidate records.